首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1561443

2024-2032 年按類型、醫療狀況、技術、最終用戶和地區分類的營運商篩選市場報告

Carrier Screening Market Report by Type, Medical Condition, Technology, End User, and Region 2024-2032

出版日期: 2024年09月10日 | 出版商:

IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023 年，全球帶因者篩檢市場IMARC Group達到 19 億美元。全球市場的主要促進因素包括遺傳技術的不斷進步、人們對早期遺傳性疾病檢測的認知和需求的提高、政府的支持性舉措、遺傳性疾病發病率的上升、新生兒篩檢計畫的擴大以及個性化醫療的日益採用。

營運商篩檢市場分析：

主要市場驅動力：遺傳技術的進步、對遺傳性疾病認知的提高、政府支持、遺傳性疾病盛行率的增加以及新生兒篩檢計畫的擴大正在推動全球市場的發展。
主要市場趨勢：攜帶者篩檢市場的主要趨勢包括擴大攜帶者篩檢的主導地位、DNA定序技術的主導作用、醫院和診所的主導地位、北美最大的市場佔有率以及肺部疾病在醫療狀況中的突出地位。
地理趨勢：北美由於先進的醫療基礎設施和高認知度而處於領先地位。歐洲緊隨其後，擴大採用基因檢測。在醫療保健投資和意識不斷提高的推動下，亞太地區出現了快速成長。
競爭格局：帶因者篩檢產業的一些主要市場參與者包括 Myriad Genetics、Invitae、Natera、Quest Diagnostics、Laboratory Corporation of America Holdings (LabCorp) 和 Illumina。這些公司憑藉先進的技術和廣泛的服務而處於領先地位。
挑戰與機會：挑戰包括監管複雜性和道德考量。機會在於技術進步、擴大市場範圍以及加強與醫療保健提供者的合作以提高服務的可及性和有效性。

營運商篩檢市場趨勢：

基因技術的不斷進步

基因技術的新興創新正在支持載體篩檢市場的成長。分子診斷測試的進步導致了更新更好的方法的發展，例如用於同時篩檢多種遺傳性疾病的下一代定序（NGS）。這些技術的發展和改進不僅有助於降低基因檢測的成本，也有助於大眾獲得基因檢測。因此，醫療保健提供者能夠提供改進和準確的攜帶者篩檢，隨著遺傳性疾病知識的不斷發展以及篩檢儀器的增強，有助於攜帶者篩檢市場的進步。

意識和需求不斷提高

由於早期遺傳性疾病檢測的需求不斷成長，帶因者篩檢市場前景樂觀。隨著越來越多的個人和夫婦希望免受此類遺傳性疾病的影響，攜帶者篩檢測試也不斷增加。衛生機構增加的教育計劃以及將遺傳諮詢納入標準醫療服務中正在支持市場的成長。此外，隨著人們對遺傳疾病的認知不斷增強，加上疾病的早期發現和預防的轉變，人們開始選擇帶因者篩檢。隨著及時檢測提高了生活品質和生殖選擇，這種趨勢預計未來將持續，並保持市場的上升趨勢。

政府角色和報銷

攜帶者篩選產業受到政府政策和行動以及報銷政策積極趨勢的推動。衛生和政府政策制定者開始認知到產前篩檢對於預防遺傳性疾病的傳播至關重要。因此，有措施將攜帶者篩檢納入國家醫療保健計劃和保險政策框架內提供的強制性服務清單中。這些測試越來越受歡迎，因為報銷政策使它們變得更便宜，因此更容易為客戶所接受。此外，政府資金也有所增加，用於支持基因篩檢技術的研究和開發，從而促進該產業的擴張。這些支持措施很有價值，因為它們有助於促進攜帶者篩檢的增加，從而增強該行業的實力。

營運商篩選市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、醫療狀況、技術和最終用戶對市場進行了分類。

按類型分類：

擴大攜帶者篩檢
- 客製化面板測試
- 預先設計的面板測試
針對性疾病帶因者篩檢

擴大的攜帶者篩檢佔據了大部分市場佔有率

該報告根據類型提供了詳細的市場細分和分析。這包括擴大攜帶者篩檢（客製化的小組測試和預先設計的小組測試）和有針對性的疾病攜帶者篩檢。根據該報告，擴大攜帶者篩檢是最大的部分。

擴大的攜帶者篩檢提供了有關包括罕見疾病在內的各種疾病的更多資訊，因此它是醫療保健提供者和患者的首選選擇。它能夠在一次測試中提供個人多種疾病攜帶者狀態的綜合結果，這推動了它的流行。它還有助於提供更好的診斷準確性，並有助於在計劃生育和管理方面做出更好的決策。人們對準父母雙方遺傳健康的日益關注，以及新的、更先進的攜帶者檢測方法的可及性，促進了更廣泛的攜帶者篩檢的持續普及，從而鞏固了市場的領先地位。

按醫療狀況分類：

肺部疾病
血液學狀況
神經系統疾病
其他

肺部疾病佔據產業最大佔有率

報告還根據醫療狀況對市場進行了詳細的細分和分析。這包括肺部疾病、血液疾病、神經系統疾病等。報告稱，肺部疾病佔據了最大的市場佔有率。

肺部疾病代表了市場上最大的細分市場。包括囊性纖維化在內的疾病更為普遍，對健康造成嚴重影響，因此，應儘早、正確地進行篩檢以控制後果。目前關於肺部疾病帶原者篩檢重要性的觀點也值得考慮，因為及時識別潛在帶原者並制定有效的治療計劃最終可以挽救患者的生命並提高他們的生活品質。可靠的篩檢測試和對帶因者領域研究的關注也在肺部疾病篩檢主導的重要市場佔有率中發揮關鍵作用。對疾病預防和基因檢測的關注也更廣泛地增強了肺部疾病在該領域的中心地位。

按技術分類：

DNA定序
聚合酶鍊式反應
微陣列
其他

DNA 定序代表了領先的細分市場

該報告基於該技術對市場進行了詳細的細分和分析。這包括 DNA 定序、聚合酶鍊式反應、微陣列等。報告稱，DNA 定序是最大的部分。

透過 DNA 定序進行的攜帶者測試已被確定為市場中最主要的技術領域。這種增強的科學透過尋找可能決定此類遺傳性疾病攜帶者狀態的可能突變來幫助表徵 DNA 材料。 DNA 定序技術的進步，例如高精度、序列資料生成效率高以及與其他方法相比成本降低等，使 DNA 定序成為首選的載體篩選技術。在遺傳性疾病和疾病的情況下需要及早做出規定，這使得它有助於提供充分和準確的遺傳資訊。隨著定序技術的進步，基因分析中的載體篩選已經更加深入和廣泛。

按最終用戶分類：

醫院和診所
參考實驗室
其他

醫院和診所在市場上表現出明顯的主導地位

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、參考實驗室等。報告顯示，醫院和診所佔據了最大的市場。

根據帶因者篩檢市場趨勢，醫院和診所成為最終用戶的主導部分。這些是客戶可以獲得基因診斷的典型醫療設施。攜帶者測試涉及進行詳盡的篩檢測試和隨後的諮詢——醫院和診所有足夠的能力透過其必要的基礎設施、人員和設備來處理這一方面。這些服務被轉化為使攜帶者篩檢廣泛普及，因為提供產前和孕前護理的機構都納入了這項服務。此外，對醫院和診所的信任和信譽促使更多的人選擇帶因者篩檢。隨著基因檢測在這些醫療機構中的現有擴展，主要參與者背後的市場基本面得到加強，這對攜帶者篩檢服務的推廣做出了積極貢獻。

按地區分類：

北美洲
- 美國
- 加拿大
亞太
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 其他
歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 俄羅斯
- 其他
拉丁美洲
- 巴西
- 墨西哥
- 其他
中東和非洲

北美市場領先，佔據最大的營運商篩選市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是攜帶者篩檢的最大區域市場。

由於更好的醫療設施、提高的意識水平以及支持進行此類基因測試的政府法律，北美佔據了最大的市場佔有率。所有主要基因檢測公司的可用性以及正在進行的遺傳學研究也對該領域處於領先地位發揮了作用。北美地區對於疾病的預防相對較重視，帶因者篩檢的使用率也比較高。此外，獲得理想的基因測試保險範圍也為市場創造了額外的需求。消費者對攜帶者篩檢的興趣不斷增加，特別是在個人化用藥和早期疾病診斷方面，北美先進的醫療保健產業及其積極的基因篩檢方法將繼續促進其在全球市場的成長。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。載體篩檢產業的一些主要市場參與者包括

富金遺傳學
基因基因有限公司 (MyDNA)
照明公司
英維泰公司
醫學基因組實驗室有限公司
無數遺傳學公司
納特拉公司
OPKO 健康公司
探索診斷
塞瑪4
賽默飛世爾科技公司

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

職業篩選公司正在迅速提高其技術進步和市場覆蓋範圍。 Myriad Genetics、Invitae、Natera 和其他各種基因檢測公司也投入資源來提高靈敏度並擴大可透過基因檢測檢測的疾病清單。他們還與醫療保健服務提供者和設施簽訂各種從屬關係和服務協議，以使其服務提供組合多樣化。這些參與者正在尋求採用 NGS 等革命性技術，使他們的攜帶者篩檢更加準確和包容。此外，他們還將加強宣傳力度，促進民眾使用帶因者篩檢。市場的關鍵策略是透過提高價格競爭力來提高可及性以及擴大領土，使某些關鍵參與者加強其地位並促進市場的發展。

營運商篩檢市場新聞：

2023 年 9 月 13 日，Devyser 和 Thermo Fisher Scientific 合作推廣實驗室服務，以推進藥物研究。目標是利用 Devyser 在其 CLIA 認證實驗室中的獨特檢測來支持他們的開發項目。
2023 年 7 月 11 日，Quest Diagnostics 推出了首個以消費者為中心的基因測試「Genetic Insights」。這項新服務幫助個人了解他們患遺傳性疾病的風險。該服務還包括個人化的健康報告和遺傳諮詢。
2023 年 3 月 2 日，Illumina Inc. 和 Myriad Genetics Inc. 宣布擴大策略夥伴關係，以擴大腫瘤同源重組缺陷 (HRD) 檢測的可及性和可用性。

本報告回答的關鍵問題：

迄今為止，全球帶因者篩檢市場表現如何，未來幾年將如何表現？
全球帶因者篩檢市場的促進因素、限制因素和機會是什麼？
每個促進因素、限制因素和機會對全球攜帶者篩檢市場有何影響？
主要區域市場有哪些？
哪些國家代表了最具吸引力的攜帶者篩檢市場？
依類型分類市場是怎麼樣的？
攜帶者篩檢市場中哪種類型最有吸引力？
基於醫療狀況的市場區隔是什麼？
攜帶者篩檢市場中最具吸引力的醫療狀況是什麼？
什麼是基於技術的市場分割？
載體篩檢市場中哪一項技術最具吸引力？
基於最終用戶的市場區隔是什麼？
載體篩選市場中哪一個對最終用戶最具吸引力？
市場競爭結構如何？
全球攜帶者篩檢市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

迄今為止，全球帶因者篩檢市場表現如何，未來幾年將如何表現？
全球帶因者篩檢市場的促進因素、限制因素和機會是什麼？
每個促進因素、限制因素和機會對全球攜帶者篩檢市場有何影響？
主要區域市場有哪些？
哪些國家代表了最具吸引力的攜帶者篩檢市場？
依類型分類市場是怎麼樣的？
攜帶者篩檢市場中哪種類型最有吸引力？
基於醫療狀況的市場區隔是什麼？
攜帶者篩檢市場中最具吸引力的醫療狀況是什麼？
什麼是基於技術的市場分割？
載體篩檢市場中哪一項技術最具吸引力？
基於最終用戶的市場區隔是什麼？
載體篩選市場中哪一個對最終用戶最具吸引力？
市場競爭結構如何？
全球攜帶者篩檢市場的主要參與者/公司有哪些？

The global carrier screening market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032. The global market is majorly driven by continual advancements in genetic technology, increasing awareness and demand for early genetic disorder detection, supportive government initiatives, rising incidence of genetic disorders, expansion of newborn screening programs, and the growing adoption of personalized medicine.

Carrier Screening Market Analysis:

Major Market Drivers: Advancements in genetic technology, rising awareness of genetic disorders, government support, increasing prevalence of genetic conditions, and expansion of newborn screening programs are driving the global market.
Key Market Trends: Key trends in the carrier screening market include the predominance of expanded carrier screening, the leading role of DNA sequencing technology, the dominance of hospitals and clinics, North America's largest market share, and the prominence of pulmonary conditions in medical condition-focused screening.
Geographical Trends: North America leads due to advanced healthcare infrastructure and high awareness. Europe follows with increasing adoption of genetic testing. Asia-Pacific shows rapid growth driven by healthcare investments and rising awareness.
Competitive Landscape: Some major market players in the carrier screening industry include Myriad Genetics, Invitae, Natera, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Illumina. These companies lead with advanced technologies and extensive service offerings.
Challenges and Opportunities: Challenges include regulatory complexities and ethical considerations. Opportunities lie in technological advancements, expanding market reach, and increasing collaborations with healthcare providers to enhance service accessibility and efficacy.

Carrier Screening Market Trends:

Continual advancements in genetic technology

Emerging innovations in genetic technology are supporting the carrier screening market growth. Advancements in molecular diagnostic testing have led to the development of newer and better methods, such as the next-generation sequencing (NGS) for screening several genetic disorders at once. These technological developments and improvements have not only contributed to the lowering of the cost of genetic testing, but also to its accessibility to the public. Healthcare providers are thus able to provide improved and accurate carrier screening, with numerous developments in the knowledge of genetic disorders to grow along with the enhancements in screening instruments contributing to the progress of the market for carrier screening.

Rising awareness and demand

The carrier screening market outlook is positive due to the rising demand for early genetic disorders detection. Carrier screening tests are also on the rise as more individuals and couples want to be protected from such inherited conditions. Increased education programs by health bodies and incorporating genetic counseling into standard healthcare services are supporting the growth of the market. Furthermore, as there is increasing awareness of genetic diseases, coupled with the shift for early detection of diseases and prevention, individuals are opting for carrier screening. This trend is expected to continue in the future, and maintain the market's upward trend, as timely detection enhances the quality of life and reproductive choices.

Government roles and reimbursements

The carrier screening industry is propelled by governmental policies and actions, as well as a positive trend in reimbursement policies. Health and government policy makers are beginning to understand that pre-natal screenings are essential in preventing the spread of genetic disorders. Consequently, there are measures to introduce carrier screening into the list of mandatory services provided within the framework of state health care programs and insurance policies. These tests are growing popular as reimbursement policies have made them cheaper and thus more accessible to clients. Also, there is an increase in government funding that supports research and development in genetic screening technologies and therefore the expansion occurring in the industry. Such supportive measures are valuable as they help to facilitate the increased use of carrier screening, which in turn strengthens the industry.

Carrier Screening Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, medical condition, technology and end user.

Breakup by Type:

Expanded Carrier Screening
- Customized Panel Testing
- Predesigned Panel Testing
Targeted Disease Carrier Screening

Expanded carrier screening accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes expanded carrier screening (customized panel testing and predesigned panel testing) and targeted disease carrier screening. According to the report, expanded carrier screening represented the largest segment.

Expanded carrier screening provides added information as to various conditions including rare ones, due to which it is a preferred option both by healthcare providers as well as the patients. Its ability to offer comprehensive results of an individual's carrier status for multiple disorders in a single test has propelled its popularity. It also helps to provide better diagnostic accuracy and assists in making better decisions as to family planning and management. The increasing focus on the genetic health of both parents-to-be and the accessibility of new and more sophisticated carrier detection methods add to the continued popularity of more extensive carrier screening, which cements the leading position of the market.

Breakup by Medical Condition:

Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others

Pulmonary conditions holds the largest share of the industry

A detailed breakup and analysis of the market based on the medical condition have also been provided in the report. This includes pulmonary conditions, hematological conditions, neurological conditions, and others. According to the report, pulmonary conditions accounted for the largest market share.

Pulmonary conditions represents the largest market segment in the market. Diseases, including cystic fibrosis are more prevalent with serious effects on health, therefore, screening should be done early and correctly to contain the consequences. Current opinions regarding the importance of carrier screening for pulmonary conditions are also worth considering, as the timely identification of the potential carriers and the development of an effective treatment plan can ultimately save the patient's life and improve their quality of living. Reliable screening tests and focus on the research aspect in the carrier field also play a key role in significant market share being dominated by the pulmonary conditions screening. The focus on disease prevention and genetic testing also bolster the centrality of pulmonary disorders in the sector more widely.

Breakup by Technology:

DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others

DNA sequencing represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes DNA sequencing, polymerase chain reaction, microarrays, and others. According to the report, DNA sequencing represented the largest segment.

Carrier testing by DNA sequencing has been identified to be the most dominant segment within the market by technology. This enhanced science helps in the characterization of DNA materials by finding possible mutations that may determine the carrier status of such inherited ailments. Advancements in DNA sequencing such as high precision, efficiency in generating sequence data and the reduced cost compared to other methods have made DNA sequencing the carrier screening technique of choice. The need to make early provisions in cases of genetic disorders and diseases makes it instrumental in offering adequate and accurate genetic information. With the advancement in sequencing technology, carrier screening has been through more depth and spectrum in genetic analysis.

Breakup by End User:

Hospitals and Clinics
Reference Laboratories
Others

Hospitals and clinics exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, reference laboratories, and others. According to the report, hospitals and clinics accounted for the largest market share.

As per the carrier screening market trends, hospitals and clinics emerged as the leading segment for end user. These are the typical medical facilities where clients can get access to genetic diagnostics. Carrier testing involves the performance of exhaustive screening tests and subsequent counseling- an aspect that hospitals and clinics are well equipped to handle through their necessary infrastructure, personnel, and equipment. These services are translated to make access to carrier screening widespread since the facilities offering prenatal and preconception care incorporate this service. Also, the trust and credibility that are attributed to hospitals and clinics push more individuals into selecting carrier screening. With the existing expansion of genetic testing across these healthcare institutions, the market fundamentals are strengthened behind the key players, which positively contributes to the promotion of carrier screening services.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest carrier screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for carrier screening.

North America is the largest market share due to better healthcare facilities, increased awareness levels, and supportive government laws to carry out such genetic tests. The availability of all major genetic testing companies and the on-going research regarding genetics also play a role in placing the area at the top. In North America, there is a relatively greater focus on the prevention of diseases, and usage of carrier screenings is also relatively high. Moreover, the access to desirable insurance coverage for genetic tests creates additional demand for the market. The increased consumer interest in carrier screenings, especially in personalized medication and early disease diagnosis, and North America's advanced healthcare industry as well as its active approach to genetic screening will continue to foster its growth in the global market.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the carrier screening industry include

Fulgent Genetics
Gene By Gene Ltd. (MyDNA)
Illumina Inc.
Invitae Corporation
MedGenome Labs Ltd.
Myriad Genetics Inc.
Natera Inc.
OPKO Health Inc.
Quest Diagnostics
Sema4
Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Career screening companies are rapidly increasing their technological advancement and market coverage. Myriad Genetics, Invitae, and Natera and various other genetic testing companies are also committing resources to the improvement of sensitivity and the expanding the list of diseases amenable to detection through genetic testing. They are also entering into various affiliation and service agreements with healthcare service providers and facilities to diversify their service delivery portfolios. These players are looking to adopt revolutionary technologies such as NGS that will enable them to make their carrier screening more accurate and inclusive. Also, they are to increase awareness efforts in promoting the use of carrier screening among the populace. Key strategies of the market identified as the improvement of accessibility by making prices more competitive, as well as the expansion of the territory, make certain critical players strengthen their positions and promote the development of the market.

Carrier Screening Market News:

On 13th September 2023, Devyser and Thermo Fisher Scientific collaborated to promote laboratory services to advance pharmaceutical research. The goal was to support their development projects utilizing Devyser's unique assays in its CLIA-certified laboratory.
On 11th July 2023, Quest diagnostics launched its first consumer-focused genetic test, genetic insights. The new service help individuals to understand their risk of developing inheritable medical conditions. The service also includes personalized health reports and access to genetic counselling.
On 2nd March 2023, Illumina Inc. and Myriad Genetics Inc. announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous recombination deficiency (HRD) testing.

Key Questions Answered in This Report:

How has the global carrier screening market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global carrier screening market?
What is the impact of each driver, restraint, and opportunity on the global carrier screening market?
What are the key regional markets?
Which countries represent the most attractive carrier screening market?
What is the breakup of the market based on the type?
Which is the most attractive type in the carrier screening market?
What is the breakup of the market based on the medical condition?
Which is the most attractive medical condition in the carrier screening market?
What is the breakup of the market based on technology?
Which is the most attractive technology in the carrier screening market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the carrier screening market?
What is the competitive structure of the market?
Who are the key players/companies in the global carrier screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Carrier Screening Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Expanded Carrier Screening
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Customized Panel Testing
  - 6.1.2.2 Predesigned Panel Testing
- 6.1.3 Market Forecast
6.2 Targeted Disease Carrier Screening
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Medical Condition

7.1 Pulmonary Conditions
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hematological Conditions
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Neurological Conditions
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Technology

8.1 DNA Sequencing
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Polymerase Chain Reaction
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Microarrays
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Reference Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Fulgent Genetics
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 Gene By Gene Ltd. (MyDNA)
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Illumina Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Invitae Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 MedGenome Labs Ltd.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Myriad Genetics Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Natera Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 OPKO Health Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Quest Diagnostics
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sema4
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Thermo Fisher Scientific Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Carrier Screening Market: Major Drivers and Challenges
Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2023
Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2023
Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2023
Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2023
Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2023
Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2023
Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Global: Carrier Screening Industry: SWOT Analysis
Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Carrier Screening Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Carrier Screening Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Carrier Screening Market Forecast: Breakup by Medical Condition (in Million US$), 2024-2032
Table 4: Global: Carrier Screening Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Carrier Screening Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Carrier Screening Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Carrier Screening Market: Competitive Structure
Table 8: Global: Carrier Screening Market: Key Players

02-2729-4219

+886-2-2729-4219